Skip to main content


Poster LMMO

Clinical studies (Prof J. De Grève):                                                                 

- tolerability and efficacy of novel systemic treatments of cancer (phase I, II, III); sponsored and academic studies

- studies in supportive care, toxicity control, end of life and geriatric oncology in collaboration with the End-Of-Life Care and other groups

- identifying and correlating biomarkers with the clinical efficacy of novel cancer treatments - a major focus is on genomic biomarker research. Investigator-initiated translational studies in following tumor types: lung cancer, brain tumors, melanoma, sarcoma and esophageal cancer

- precision basket trials in the context of the Belgian Precision initiative